Stock listing
Acarix Ab
Selected listing: ACARIX · OMXSTO · SEK · SE
Acarix Ab (Stockholm:ACARIX), Health Technology. Latest release Sep 11, 2026: Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far…
- Ticker
- Stockholm:ACARIX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Stockholm
- Currency
- SEK
About Acarix Ab
Acarix Ab is a public company listed on the Swedish market under the ticker ACARIX. Acarix focuses on developing innovative diagnostic solutions for cardiovascular diseases.
Latest news from Acarix Ab
Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far Fewer False Positives Than Standard Blood Test
September 11, 2026
Acarix Publishes Second Quarter and First Half 2026 Results
August 13, 2026
Acarix Receives Regulatory Approval for the CADScor(R) System in the UAE (United Arab Emirates)
August 11, 2026
Acarix Receives Regulatory Approval for the CADScor®System in the United Arab Emirates
August 10, 2026
Announcement from the annual general meeting in Acarix AB
June 17, 2026